Genistein Combined Polysaccharide (GCPÒ)
has gained the attention of researchers worldwide through the
International AHCC Research Association, founded in 1986 to promote
the further study of AHCC. Each year since 1994, over 350 medical
doctors and researchers have gathered in Sapporo, Japan for the AHCC
Research Association symposiums, where GCP was originally
Various clinical trials have demonstrated GCP mechanism as anti-angiogenesis, apoptosis and immune system support.* GCP has been the subject of numerous clinical studies conducted at prestigious institutions such as Kansai University, Osaka University, Kitasato University and the Tajima Clinic in Japan and in the United States at Columbia University and the University of California at UC Davis.